Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 215,133,521 papers from all fields of science
Search
Sign In
Create Free Account
PD 85639
Known as:
Benzeneacetamide, 3-(2,6-dimethyl-1-piperazinyl)-alpha-phenyl-alpha-propyl-
, PD-85639
, PD85,639
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Benzeneacetamides
Piperidines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Synthesis and pharmacological evaluation of substituted naphth[1,2,3-de]isoquinolines (dinapsoline analogues) as D1 and D2 dopamine receptor ligands.
A. Qandil
,
M. Lewis
,
A. Jassen
,
S. Leonard
,
R. Mailman
,
D. Nichols
Bioorganic & Medicinal Chemistry
2003
Corpus ID: 25891554
1993
1993
Specific binding of the novel Na+ channel blocker PD85,639 to the alpha subunit of rat brain Na+ channels.
W. Thomsen
,
S. Hays
,
J. Hicks
,
R. Schwarz
,
W. Catterall
Molecular Pharmacology
1993
Corpus ID: 25400541
The local anesthetic-like Na+ channel-blocking drug [3H]PD85639 [alpha-([4-3H]phenyl)-N-[3-(2,6-dimethyl-1-piperizinyl)-alpha…
Expand
1993
1993
Inhibition of Na+ channels by the novel blocker PD85,639.
D. Ragsdale
,
R. Numann
,
W. Catterall
,
T. Scheuer
Molecular Pharmacology
1993
Corpus ID: 12099050
This study examined the actions of the novel Na+ channel blocker PD85,639. In whole-cell voltage-clamp recordings from Chinese…
Expand
1982
1982
Synthesis and pharmacological evaluation of reduced diastereoisomeric and quaternary ammonium derivatives of calcium antagonistic (methylenedioxy)indenes on the isolated rat aorta.
D. Witiak
,
R. J. Brumbaugh
,
R. Heaslip
,
R. Rahwan
Journal of Medicinal Chemistry
1982
Corpus ID: 11934446
Based upon findings that 2-n-propyl- and 2-n-butyl-3-(diethylamino)-5,6-(methylenedioxy)indenes (1 and 2) inhibit a variety of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE